文献速递哮喘

激素替代治疗与新发哮喘风险:丹麦注册研究

Hormone Replacement Therapy and Development of New Asthma.
PubMed 文献 · Chest · 2021-03-26

该研究基于丹麦1995至2018年注册数据开展巢式病例对照研究,纳入34,533例哮喘女性与345,116例非哮喘女性,年龄40至65岁。调整年龄、家庭收入和教育水平后,活跃HRT与新发哮喘风险升高相关(HR 1.63,95%CI 1.55-1.71,P<.001);终止HRT的哮喘女性后续停药风险亦升高(HR 2.12,95%CI 1.94-2.33,P<.001)。

要点

  • 绝经期女性使用HRT与新发哮喘风险升高相关,HR为1.63。
  • 哮喘女性停用HRT后更容易停用哮喘治疗,HR为2.12。
  • 处方HRT时应告知新发气道症状可能,必要时考虑停药。

核心结论

  • HRT可能参与成熟女性新发哮喘的发生。
  • 停用HRT的哮喘女性更可能随后停用哮喘治疗。

研究设计与样本

  • 基于丹麦注册数据的巢式病例对照研究,时间范围为1995年6月1日至2018年12月31日。
  • 哮喘定义为2年内两次领取吸入性糖皮质激素处方。
  • HRT定义为6个月内两次领取女性性激素处方。
  • 纳入34,533例哮喘女性与345,116例非哮喘女性,年龄40至65岁。
  • 采用条件logistic回归模型分析。

主要发现

  • 多因素分析调整年龄、家庭收入和教育水平后,活跃HRT与新发哮喘风险的HR为1.63(95%CI 1.55-1.71;P<.001)。
  • 哮喘女性终止HRT后停用哮喘治疗的HR为2.12(95%CI 1.94-2.33;P<.001)。

临床怎么用

  • 处方HRT的临床医生及接受HRT的女性应意识到可能新发气道症状。
  • 出现新发气道症状时可考虑停用HRT。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hormone replacement therapy (HRT) is prescribed to millions of women worldwide. Previous studies have suggested that HRT has both protective and harmful effects in asthma. RESEARCH QUESTION: Is HRT in menopause associated with new development of asthma? STUDY DESIGN AND METHODS: We undertook a nested case-control study based on the Danish registers from June 1, 1995, through December 31, 2018. A diagnosis of asthma was defined as two redeemed prescriptions of inhaled corticosteroids within 2 years. HRT was defined as two redeemed prescriptions of female sex hormones within 6 months. Data were analyzed using a conditional logistic regression model. RESULTS: We included 34,533 women with asthma vs 345,116 women without asthma between 40 and 65 years of age. In a multivariate analysis adjusted for age, household income, and educational level, active HRT resulted in a hazard ratio (HR) of 1.63 (95% CI, 1.55-1.71; P < .001) of new asthma development. Women with asthma who terminated HRT were likely to discontinue their asthma treatment subsequently (HR, 2.12; 95% CI, 1.94-2.33; P < .001). INTERPRETATION: HRT seems to play a role in the development of asthma in mature women. Clinicians prescribing HRT and women receiving HRT should be aware that new airway symptoms can develop, and discontinuation of HRT should be considered.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Hansen ESH, Aasbjerg K, Moeller AL, et al. Hormone Replacement Therapy and Development of New Asthma. Chest. 2021. PMID: 33775661. doi:10.1016/j.chest.2021.01.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。